Prospective study of vaginal bacteria flora and other risk factors for vulvovaginal candidiasis

Journal of Infectious Diseases

Volumn 199, Issue 12, 2009, Pages 1883-1890

  McClelland, R Scott ^a,b,c,d   Richardson, Barbra A ^b   Hassan, Wisal M ^b   Graham, Susan M ^a,d   Kiarie, James ^a,e   Baeten, Jared M ^a,e   Mandaliya, Kishorchandra ^c,f   Jaoko, Walter ^d   Ndinya Achola, Jeckoniah O ^d   Holmes, King K ^a,c  

^a Departments of Laboratory Medicine   (United States)

^b Department of Epidemiology ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Departments of Medical Microbiology   (Kenya)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Department of Obstetrics and Gynaecology   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BENZATHINE PENICILLIN; CIPROFLOXACIN; CLOTRIMAZOLE; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCONAZOLE; LEVOFLOXACIN; METRONIDAZOLE; NORFLOXACIN; PLACEBO; POTASSIUM HYDROXIDE;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA CANDIDIASIS; VAGINA SECRETION; VAGINITIS; BACTERIUM; CLASSIFICATION; COHORT ANALYSIS; ISOLATION AND PURIFICATION; KENYA; MICROBIOLOGY; PROSPECTIVE STUDY; PROSTITUTION; RISK; RISK FACTOR; VAGINA;

ADULT; BACTERIA; CANDIDIASIS, VULVOVAGINAL; COHORT STUDIES; FEMALE; HUMANS; KENYA; ODDS RATIO; PROSPECTIVE STUDIES; PROSTITUTION; RISK FACTORS; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 67650498998     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599213     Document Type: Article

References (38)

1. Sobel JD, Faro S, Force RW, et. al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178:203-11.
2. Martin HL Jr, Nyange PM, Richarson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-9.
3. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1.998; 12:75-84.
4. Hester RA, Kennedy SB. Candida infection as a risk factor for HIV transmission. J Womens Health (Larchmt) 2003; 12:487-94.
5. Kilmarx PH, Limpakarnjanarat K, Mastro TD, et al. HIV-1 seroconverson in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS 1998; 12: 1889-98.
6. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998; 12:1699-706.
7. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
8. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transrn Dis 2001; 28:579-97.
9. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006; 368:489-504.
10. Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369:1961-71.
11. Auger P, Joly J. Microbial flora associated with Candida albicans vulvovaginitis. Obstet Gynecol 1980; 55:397-401.
12. Sobel JD. Vulvovaginal candidiasis. In: Holmes KK, Mardh P, Sparling PF, et al., eds. Sexually transmitted diseases. 4th ed. New York NY: McGraw-Hill, 2007:823-38.
13. McClelland RS, Richardson BA, Hassan WM, et al. Improvement of vaginal health for Kenyan, women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis 2008; 197:1361-8.
14. World Health Organization (WHO). Guidelines for the management of sexually transmitted infections. Geneva, Switzerland: WHO, 2003:1-91.
15. World Health Organization (WHO), Centers for Disease Control and Prevention. Guidelines for appropriate evaluations of HIV testing technologies in Africa. Harare, Zimbabwe: WHO Regional Office for Africa, 2001:1-48.
16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin. Microbiol 1991; 29:297-301.
17. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989; 27:251-6.
18. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001; 185:380-5.
19. Bergman JJ, Berg AO, Schrieeweiss R, Heidrich FE. Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis. J Fam Pract 1984; 18:549-52.
20. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-8.
21. Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in nonpregnant: women: a longitudinal study. Obstet Gynecol 2004; 104:926-30.
22. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria, associated with bacterial vaginosis. N Engl J Med 2005; 33: 1899-911.
23. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-63.
24. Valore EV, Wiley DJ, Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 2006; 74:5693-702.
25. Fidel PL, Jr., Barousse M, Espinosa T, et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogen esis of vulvovaginal candidiasis. Infect Immun 2004; 72:2939-46.
26. Oller LZ. Prevention of post-metronidazole candidosis with amphotericin B pessaries. Br J Verier Dis 1969; 45:1.63-6.
27. Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006; 194:1283-9.
28. Bradshaw CS, Morton AN, Hocking J, et: al. High, recurrence rates of bacterial, vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478-86.
29. Maraki S, Margioris AN, Orfanoudaki E, et al. Effects of doxycycline, metronidazole and their combination on Candida species colonization of the human, oropharynx, intestinal lumen and vagina. J Chemother 2003; 15:369-73.
30. Schaaf VM, Perez-Stable EJ, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 1990; 150:1929-33.
31. Anderson D, Johnson PM. Cervicovaginal virus secretion in HIV-infected women. J Acquir Immune Defic Syndr 1994; 7:204.
32. Sobel JD, Muller G, Buckley HR. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect: Immun 1984; 44:576-80.
33. Merson-Davies LA, Odds FC, Malet R, et al. Quantification of Candida albicans morphology in vaginal smears. Eur J Obstet Gynecol Reprod Biol 1991; 42:49-52.
34. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet: Gynecol. 1985; 152:924-35.
35. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998; 92:757-65.
36. Anukam KC, Osazuwa EO, Ahonkhai I, Reid G. Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis 2006; 33:59-62.
37. McClelland RS, Ndinya-Achola JO, Baeten JM. Reply to: "Is Vaginal. Washing Associated with Increased Risk of HIV-1 Acquisition?" AIDS 2006; 20:1348-9.
38. Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis 2005; 192:1372-80.